Author Archives - c.schmidt@augmenticon.ch

InnoSuisse and Augmenticon fund AR-/MR-Technology Project

AUGMENTICON™ enters into a collaboration with the Center for Radiopharmaceutical Sciences, D-CHAB at ETH-Zurich and the Institute of Interactive Technologies at FHNW-Windisch to develop AR & mixed reality tools to extend AUGMENTICON`s SHARE and ASSYST platform technology. The project is jointly funded by the Swiss Innovation Agency, Innosuisse, and AUGMENTICON™. Zurich, Switzerland – AUGMENTICON™ a…

Friedrich Gause joins AUGMENTICON

Friedrich Gause joins AUGMENTICON as Senior Vice President Finance & Strategy Development Zurich, Switzerland – AUGMENTICONTM, a privately held Augmented-/Mixed-Reality (AR/MR-)Technology company, developing novel tools for a cost-effective, high-quality manufacturing of (radio-)pharmaceuticals, announces the appointment of Friedrich Gause as its Senior Vice President Finance and Strategy Development. Mr. Gause will take care of developing AUGMENTICON’s corporate…

Imprint

Information according to SEC. 5 TMG (German Telemedia Act): Augmenticon AGEuropa-Strasse 19a8152 GlattbruggSwitzerland Contact Information Tel.: +41 (0) 44 621 81 77Email: info@augmenticon.ch Commercial register: CHE-359.971.830Court of registration: Zürich, Switzerland Represented by: Dr. Matthias Friebe, Dr. Christian SchmidtVAT-ID : CHE-359.971.830 MWST Disclaimer of Liability Liability for Contents As a service provider we are responsible according to…

Privacy Policy

We are very delighted that you have shown interest in our enterprise. Data protection is of a particularly high priority for the management of the Augmenticon AG . The use of the Internet pages of the Augmenticon AG is possible without any indication of personal data; however, if a data subject wants to use special…